Evidence map›Paper›PMID 37420843›Full record

ArticleSensors (Basel, Switzerland)2023

Transformer-Based Approach to Melanoma Detection.

Giansalvo Cirrincione, Sergio Cannata, Giovanni Cicceri, Francesco Prinzi, Tiziana Currieri, Marta Lovino, Carmelo Militello, Eros Pasero, Salvatore Vitabile

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Giansalvo CirrincioneDépartement Electronique-Electrotechnique-Automatique (EEA), University of Picardie Jules Verne, 80000 Amiens, France.ORCID 0000-0002-2894-4164
Sergio CannataDepartment of Electronics and Telecommunications, Politecnico di Torino, 10129 Turin, Italy.ORCID 0000-0001-7895-9519
Giovanni CicceriDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University of Palermo, 90127 Palermo, Italy.ORCID 0000-0002-1498-2215
Francesco PrinziDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University of Palermo, 90127 Palermo, Italy.ORCID 0000-0002-8152-3297
Tiziana CurrieriDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University of Palermo, 90127 Palermo, Italy.ORCID 0009-0007-8062-4233
Marta LovinoDepartment of Engineering Enzo Ferrari, University of Modena and Reggio Emilia, 41125 Modena, Italy.ORCID 0000-0001-7124-8319
Carmelo MilitelloInstitute for High-Performance Computing and Networking (ICAR-CNR), Italian National Research Council, 90146 Palermo, Italy.ORCID 0000-0003-2249-9538
Eros PaseroDepartment of Electronics and Telecommunications, Politecnico di Torino, 10129 Turin, Italy.ORCID 0000-0002-2403-1683
Salvatore VitabileDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University of Palermo, 90127 Palermo, Italy.ORCID 0000-0002-2673-8551

Funding

University of Palermo grant EUROSTART, CUP B79J21038330001, project TRUSTAI4NCDI
6 · The paper itself

Abstract

Melanoma is a malignant cancer type which develops when DNA damage occurs (mainly due to environmental factors such as ultraviolet rays). Often, melanoma results in intense and aggressive cell growth that, if not caught in time, can bring one toward death. Thus, early identification at the initial stage is fundamental to stopping the spread of cancer. In this paper, a ViT-based architecture able to classify melanoma versus non-cancerous lesions is presented. The proposed predictive model is trained and tested on public skin cancer data from the ISIC challenge, and the obtained results are highly promising. Different classifier configurations are considered and analyzed in order to find the most discriminating one. The best one reached an accuracy of 0.948, sensitivity of 0.928, specificity of 0.967, and AUROC of 0.948.

Indexed as

MelanomaSkin NeoplasmsDermoscopyDNA DamageHumansartificial intelligencedecision-making supportmelanoma detectionskin cancervision transformers

Identifiers

PMID37420843
PMCPMC10304033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.